News

Shape-shifting catalyst enables powerful, broad method for adding hydroxyl groups.

A grant from the New York-based foundation will fuel expansion of DETECT, Scripps Research’s sensor-based study for real-time digital detection of viral illness.    

Strong immune responses to unchanging, conserved parts of the 2009 pandemic H1N1 flu virus suggest strategies for effective universal influenza vaccines.

FDA-approved drugs or experimental drugs with ample health data could be rapidly tested in humans for treatment of COVID-19.

Pandit will provide leadership and medical oversight for a growing portfolio of digital trials and data science research programs.

The novel drug created at Scripps Research has achieved a second FDA approval, this time for ulcerative colitis, as clinical trials continue for Crohn’s disease.

Scientists from Scripps Research investigated how the immune system’s previous exposure to cold-causing coronaviruses impact immune response to COVID-19. 

The findings provide direction for future vaccines or therapies that may offer broader protection against variants.

Proteins that enable the sense of touch in humans have an evolutionary cousin that helps plants grow their root systems.

A total of 42 graduates are earning PhDs after completing their academic journey at the Skaggs Graduate School of Chemical and Biological Sciences.

The design provides several advantages over standard vaccine approaches for Ebola and related viruses that continue to threaten global health.

Based on the Florida campus of Scripps Research, Renata devises efficient chemical techniques for recreating valuable compounds found in nature.  

Breakthrough research provides a deeper understanding of enzymes that shape many facets of health.  

Blackmond’s discoveries have propelled drug development and shed new light on complex chemistry in the natural world.

Donna Blackmond, Marisa Roberto and Xiang-Lei Yang have been honored with endowed chairs in recognition of their scientific leadership and impactful discoveries.

To create memories, the brain constantly adapts to new information and stores memories by building connections among neurons.

Results are an important step in the development of a broader-acting treatment for Ebola and related viruses.

A genetic mutation linked to autism causes significant undergrowth of brain tissue. An existing medicine appears to rescue the condition in mouse studies.

Study reveals how T cells in the small intestine respond to bile acids, offering localized treatment direction for a cause of chronic illness.

An international team, including scientists from Scripps Research, helped find answers after a man became sick for a second time with Ebola and sparked a transmission chain of more than 90 cases.

Martin, former CEO and executive chairman of Gilead Sciences, made pivotal impacts on global public health over the course of an impressive career spanning science and business.

The findings may lead to a better understanding of social disorders such as autism or depression.

A genetic analysis of virus samples suggests that the UK-originating variant, which is 40-50 percent more transmissible, entered the country in late November 2020.

Results from studies in mice suggest the protein-based vaccine could potentially serve as a booster shot to cover emerging COVID-19 variants.